Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening

Suprabhat Giri; Sukanya Bhrugumalla; Akash Shukla; Sagar Gangadhar; Srujan Reddy; Sumaswi Angadi; Leela Shinde; Aditya Kale

doi:10.1016/j.ajg.2024.01.013

Q2 2025

Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening

Suprabhat Giri · Sukanya Bhrugumalla · Akash Shukla · Sagar Gangadhar · Srujan Reddy · Sumaswi Angadi · Leela Shinde · Aditya Kale

10.1016/j.ajg.2024.01.013 406 Views 7 Citations

Citations

406

Views

Abstract not available for this publication.

Cite this Article (APA)

Suprabhat, G., Sukanya, B., Akash, S., Sagar, G., Srujan, R., Sumaswi, A., Leela, S., Aditya, K. (2025). Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2024.01.013